news in brief
STA to open catalyst screening centre in Changzhou in November
STA Pharmaceutical Co is setting up a metal catalyst-screening center at its facility in Changzhou, China.
The firm – a subsidiary of WuXi AppTec – said the centre would support screening activities for metal catalysts, ligands, bases, acids, chemical resolving reagents and amide formation coupling reagents.
STA said the center would open next month adding that staff in training at its facility in Shanghai will relocate to Changzhou when the facility is up and running.
News of the new center comes just months after WuXi merged STA’s active pharmaceutical ingredient (API) business with its development services operation.
Earlier this year STA told us it would employ a staff of 300 people at the Changzhou site, including 230 process chemists and 70 analytical chemists.
